知镜 Cognispect · 医学文献与研究工作台

Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants.

Karalar Pekuz OK, Teke Kisa P, Yildiz S, Kocabey M, Zubarioglu T, Arslan Gulten Z, Sezen ES, Er E, Pekuz S, Kadioglu Yilmaz B, Kirmizitas M, Ister MB, Kulu B, Hazan F, Kilic M, Unal Uzun O, Kiykim E, Aydin HI, Erdol S, Aktuglu Zeybek AC, Arslan N.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026-10-02 · PMID 42825826

文献摘要

Methylene tetrahydrofolate reductase (MTHFR) deficiency is a rare inherited metabolic disorder that impairs myelination and brain development, leading to primary clinical manifestations, particularly neurological deficits. The aim of this study was to comprehensively describe the clinical presentation, biochemical profile, and molecular spectrum of patients with MTHFR deficiency. This multicenter, retrospective, descriptive study evaluated the medical records of 19 patients diagnosed with MTHFR deficiency at ten metabolic disease centers. A total of 13 patients had early-onset disease. In the early-onset group, all patients had varying degrees of neurodevelopmental delay. The median diagnostic delay from the first symptom to diagnosis was 3 months in early-onset cases and 118 months in late-onset cases. MTHFR deficiency exhibits a broad clinical spectrum, with acute deterioration possible even in chronically affected patients. MTHFR deficiency should be considered among treatable neurometabolic disorders in patients with otherwise unexplained neurodevelopmental or neuropsychiatric manifestations, particularly when accompanied by additional neurological findings.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。